Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases

PURPOSE: The aim of this study was to compare disease-free survival (DFS) and overall survival (OS) between clinically node-positive breast cancer patients, treated with neoadjuvant chemotherapy (NAC), with axillary pathologic complete response (ypN0), residual axillary isolated tumor cells or micro...

Descripción completa

Detalles Bibliográficos
Autores principales: van Nijnatten, T. J. A., Simons, J. M., Moossdorff, M., de Munck, L., Lobbes, M. B. I., van der Pol, C. C., Koppert, L. B., Luiten, E. J. T., Smidt, M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387009/
https://www.ncbi.nlm.nih.gov/pubmed/28213782
http://dx.doi.org/10.1007/s10549-017-4157-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387009/
https://www.ncbi.nlm.nih.gov/pubmed/28213782
http://dx.doi.org/10.1007/s10549-017-4157-0

Ejemplares similares